Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor (Q39009470)
Jump to navigation
Jump to search
scientific article published on 29 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor |
scientific article published on 29 March 2014 |
Statements
1 reference
Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor (English)
1 reference
Wei-Qing Li
1 reference
Hong-Yu Yu
1 reference
Yi-Ming Li
1 reference
Xiang Wang
1 reference
Jin He
1 reference
Hong-Zhu Yan
1 reference
Dao-Hua Yang
1 reference
Xiao-Jun Wu
1 reference
Li-Jun Hou
1 reference
Hui-Min Liu
1 reference
Chun-Yan Xia
1 reference
Yi-Cheng Lu
1 reference
29 March 2014
1 reference
1 reference
446
1 reference
4
1 reference
1261-1267
1 reference
Identifiers
1 reference
1 reference